BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 36269638)

  • 1. High-throughput mass cytometry staining for deep phenotyping of human natural killer cells.
    Ben Amara A; Rouviere MS; Fattori S; Wlosik J; Gregori E; Boucherit N; Bernard PL; Nunès JA; Vey N; Luche H; Gorvel L; Olive D; Chretien AS
    STAR Protoc; 2022 Dec; 3(4):101768. PubMed ID: 36269638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for identification and computational analysis of human natural killer cells using flow cytometry and R.
    Kroll K; Reeves RK
    STAR Protoc; 2023 Mar; 4(1):102044. PubMed ID: 36853664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified mass cytometry protocol for in-plate staining, barcoding, and cryopreservation of human PBMC samples in clinical trials.
    Abrecht C; Hallisey M; Dennis J; Nazzaro M; Brainard M; Hathaway E; Schork AN; Hodi FS; Severgnini M; Baginska J
    STAR Protoc; 2022 Jun; 3(2):101362. PubMed ID: 35573480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional phenotyping of hepatic lymphocytes in murine MASH by mass cytometry.
    Barrow F; Fredrickson G; Wang H; Revelo XS
    STAR Protoc; 2023 Dec; 4(4):102743. PubMed ID: 37995192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harmonized analysis of PBMC by mass cytometry.
    Schulz AR; Rademacher J; Bockhorn V; Mei HE
    Methods Cell Biol; 2024; 186():107-130. PubMed ID: 38705596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for immunophenotyping out-of-hospital cardiac arrest patients.
    Yamada K; Menon JA; Kim Y; Cheng C; Chen W; Shih JA; Villasenor-Altamirano AB; Chen X; ; Tamura T; Merriam LT; Kim EY; Weissman AJ
    STAR Protoc; 2024 Mar; 5(1):102874. PubMed ID: 38310512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical 10-Color T-Cell Panel for Phenotyping Diverse Populations Using Spectral Flow Cytometry: A Beginner's Guide.
    Zargaran S; Oveisi M; Sun C; Barbour A; Glogauer M
    Curr Protoc; 2024 Mar; 4(3):e1020. PubMed ID: 38529787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring trogocytosis between ovarian tumor and natural killer cells.
    Delgado-Gonzalez A; Huang YW; Porpiglia E; Donoso K; Gonzalez VD; Fantl WJ
    STAR Protoc; 2022 Jun; 3(2):101425. PubMed ID: 35693208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol to examine immune subpopulations in murine conjunctiva and lacrimal gland using flow cytometry.
    Ma B; Zhou Y; Duan H; Sun Z; Han W; Qi H
    STAR Protoc; 2024 Mar; 5(1):102921. PubMed ID: 38421865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for the analysis of hematopoietic lineages in the whole kidney marrow of adult zebrafish.
    Mahony CB; Monteiro R
    STAR Protoc; 2024 Mar; 5(1):102810. PubMed ID: 38261517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A redox-based characterization of human immune cell subsets by polychromatic flow cytometry.
    Pitsillidou C; Muradore I; Pontarini E; Bertolotti M; Roberto A
    STAR Protoc; 2023 Dec; 4(4):102632. PubMed ID: 37838948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep phenotyping characterization of human unconventional CD8
    Orta-Resendiz A; Petitdemange C; Schmutz S; Jacquelin B; Novault S; Huot N; Müller-Trutwin M
    STAR Protoc; 2023 Dec; 4(4):102734. PubMed ID: 38032799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for simultaneous analysis of peripheral and intratumoral lymphocyte function by flow cytometry.
    Daumoine S; Hampe L; Limagne E; Ghiringhelli F; Thibaudin M
    STAR Protoc; 2023 Dec; 4(4):102658. PubMed ID: 37910510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of immune populations in the tumor microenvironment of diffuse midline glioma orthotopic mouse models by flow cytometry.
    Ausejo-Mauleon I; Labiano S; Alonso MM
    STAR Protoc; 2024 Mar; 5(1):102803. PubMed ID: 38159270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for isolation of tumor-derived extracellular vesicles and functional studies on human T cell subsets.
    Swatler J; Targońska A; Turos-Korgul L; Mosieniak G; Piwocka K
    STAR Protoc; 2024 Apr; 5(2):103011. PubMed ID: 38613780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass cytometry as a tool in target validation and drug discovery.
    Watson ECR; Baker W; Ahern D; Loi D; Cribbs AP; Oppermann U
    Methods Enzymol; 2023; 690():541-574. PubMed ID: 37858540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Mass Cytometry for In Situ Immune Profiling.
    Hu K; Harman A; Baharlou H
    Methods Mol Biol; 2024; 2779():407-423. PubMed ID: 38526797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized high-dimensional spectral cytometry protocol and panels for whole blood immune phenotyping in clinical and translational studies.
    Dott T; Culina S; Chemali R; Mansour CA; Dubois F; Jagla B; Doisne JM; Rogge L; Huetz F; Jönsson F; Commere PH; Di Santo J; Terrier B; Quintana-Murci L; Duffy D; Hasan M;
    Cytometry A; 2024 Feb; 105(2):124-138. PubMed ID: 37751141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond 40 fluorescent probes for deep phenotyping of blood mononuclear cells, using spectral technology.
    Schmutz S; Commere PH; Montcuquet N; Cumano A; Ait-Mansour C; Novault S; Hasan M
    Front Immunol; 2024; 15():1285215. PubMed ID: 38629063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry and immunohistochemistry of the mouse dural meninges for immunological and virological assessments.
    Roussel-Queval A; Rebejac J; Eme-Scolan E; Paroutaud LA; Rua R
    STAR Protoc; 2023 Mar; 4(1):102119. PubMed ID: 36853673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.